Table 2.
Association of sex-standardized log-leptin with incident all-cause dementia and incident Alzheimer’s disease
All-cause Dementia | Alzheimer’s Disease | |||||
---|---|---|---|---|---|---|
Hazard Ratio | Hazard Ratio | |||||
Model | Cases/N | (95% CI) | P | Cases/N | (95% CI) | P |
A. Age- and sex-adjusted | 111/785 | 0.70 [0.57–0.85] | <0.001 | 89/785 | 0.58 [0.47–0.73] | <0.001 |
B. adjusting for basic risk factors* | 98/657 | 0.68 [0.55–0.85] | <0.001 | 79/657 | 0.57 [0.45–0.72] | <0.001 |
C. Model B plus vascular risk factors (WHR)† | 95/641 | 0.68 [0.54–0.87] | 0.002 | 77/641 | 0.60 [0.46–0.79] | <0.001 |
C2. Model B plus vascular risk factors (BMI)§ | 96/643 | 0.75 [0.56–1.02] | 0.063 | 77/643 | 0.64 [0.46–0.89] | 0.008 |
D. Model C plus ΔWHR | 90/608 | 0.72 [0.56–0.94] | 0.014 | 73/608 | 0.64 [0.48–0.85] | 0.002 |
E. Model C plus CES-D scale | 91/629 | 0.66 [0.51–0.84] | 0.001 | 74/629 | 0.59 [0.45–0.78] | 0.001 |
Adjustment for age, sex, plasma homocysteine in the top age-specific quartile, APO E ε4-genotype
Adjustment for age, sex, plasma homocysteine in the top age-specific quartile, APO E ε4-genotype, WHR, systolic blood pressure, antihypertensive treatment, diabetes, smoking, atrial fibrillation
Adjustment for age, sex, plasma homocysteine in the top age-specific quartile, APO E-genotype, BMI, systolic blood pressure, antihypertensive treatment, diabetes, smoking, atrial fibrillation.
Hazard ratios are per one-SD increment in sex-standardized log-leptin.
Abbreviations: WHR, waist-to-hip ratio; APO E, apolipoprotein E; CI, confidence interval; ΔWHR, change in WHR from exam 21 to exam 22 (when leptin was assayed) CES-D, center for epidemiologic studies depression scale.
The number of individuals in the denominator decreased with the number of covariates in the model, because some covariates were not available in every participant